 Liposomes
"Liposomes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins.
| Descriptor ID |
D008081
|
| MeSH Number(s) |
D25.479.517 D26.255.260.517 J01.637.051.479.517 J01.637.087.500.517
|
| Concept/Terms |
Transferosomes- Transferosomes
- Transferosome
- Ultradeformable Liposomes
- Liposome, Ultradeformable
- Liposomes, Ultradeformable
- Ultradeformable Liposome
- Liposomes, Ultra-deformable
- Liposome, Ultra-deformable
- Liposomes, Ultra deformable
- Ultra-deformable Liposome
- Ultra-deformable Liposomes
|
Below are MeSH descriptors whose meaning is more general than "Liposomes".
Below are MeSH descriptors whose meaning is more specific than "Liposomes".
This graph shows the total number of publications written about "Liposomes" by people in this website by year, and whether "Liposomes" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 1 | 4 | 5 | | 1998 | 1 | 0 | 1 | | 1999 | 0 | 3 | 3 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 4 | 5 | | 2002 | 0 | 2 | 2 | | 2003 | 1 | 3 | 4 | | 2004 | 1 | 3 | 4 | | 2005 | 1 | 4 | 5 | | 2006 | 4 | 4 | 8 | | 2007 | 0 | 2 | 2 | | 2008 | 2 | 5 | 7 | | 2009 | 3 | 3 | 6 | | 2010 | 1 | 3 | 4 | | 2011 | 1 | 4 | 5 | | 2012 | 2 | 5 | 7 | | 2013 | 2 | 5 | 7 | | 2014 | 4 | 6 | 10 | | 2015 | 2 | 3 | 5 | | 2016 | 1 | 2 | 3 | | 2017 | 4 | 3 | 7 | | 2018 | 0 | 3 | 3 | | 2019 | 2 | 5 | 7 | | 2020 | 1 | 1 | 2 | | 2021 | 3 | 4 | 7 | | 2022 | 2 | 10 | 12 | | 2023 | 2 | 15 | 17 | | 2024 | 4 | 20 | 24 | | 2025 | 1 | 19 | 20 | | 2026 | 1 | 14 | 15 |
To return to the timeline, click here.
Below are the most recent publications written about "Liposomes" by people in Profiles.
-
King HAD, Subra C, Tourtellott E, Swafford I, Basu S, Rossman M, Phillips L, Obarorakpor N, Ding S, Ferrari MG, Beck Z, Lewitus E, Bai H, Dong M, Slike BM, Kim D, Dussupt V, Mendez-Rivera L, Eisel N, Zhang L, Williams LD, Tomaras GD, Finzi A, Matyas GR, Krebs SJ, Rolland M, Rao M, Paquin-Proulx D, Bolton DL. Rapid and robust immune response boosting with potent, next-generation adjuvant in viral vector-primed primates. J Virol. 2026 Aug 18; 100(8):e0038926.
-
Padilla MS, Li JJ, Zhang Q, Patwari K, Shi S, Yamagata HM, Joseph RA, Hymms BN, Teerdhala SV, Fitzgerald E, Chalom OZ, Gupta K, Alameh MG, Weissman D, Le AD, Mitchell MJ. Lipid Nanoparticle Co-Delivery of mRNA and a Small Molecule Drug for Oral Cancer Chemoimmunotherapy. Adv Mater. 2026 Aug; 38(47):e73721.
-
Sharp EE, Laforest L, Zhang Y, Xu KL, Cheng Z, Burdick JA, Gullbrand SE, Mauck RL. Streptavidin functionalized hyaluronic acid hydrogels for controlled and customizable drug delivery. Acta Biomater. 2026 Sep; 221:77-86.
-
Zeng Y, Xu J, Wang J, Xue L, Liu J, Geisler HC, Ma X, Melamed JR, Shi Q, Padilla MS, Luo Z, Zhu J, Thatte AS, Figueroa-Espada CG, Ang MJY, Murray AM, Yamagata HM, Kim D, Metzloff AE, Weissman D, Mitchell MJ. mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity. Proc Natl Acad Sci U S A. 2026 Jul 14; 123(28):e2525718123.
-
Borhan B, Murray AM, Saei AA, Ghaffari B, Jackson JE, Mohammed N, Mitchell MJ, Vali H, Whitehead KA, Mahmoudi M. Influence of protein aggregates, extracellular vesicles, and lipoprotein fusion on ionizable lipid nanoparticles protein corona analysis. Nat Commun. 2026 06 12; 17(1).
-
Han X, Xu Y, Ricciardi AS, Xu J, Xiang Y, Palanki R, Chowdhary V, Xue L, Gong N, Alameh MG, Peranteau WH, Wilson JM, Reker D, Weissman D, Mitchell MJ. Plug-and-play assembly of biodegradable ionizable lipids for potent mRNA delivery and gene editing in vivo. Proc Natl Acad Sci U S A. 2026 Jun 02; 123(22):e2528144123.
-
Kim D, Moon SJ, Han EL, Feng E, Murray AM, Wang J, Liu W, Kong G, June CH, Mitchell MJ. HITE: HIV Inspired Lipid Nanoparticle Platform for CAR T Cell Engineering. Nano Lett. 2026 May 06; 26(17):5668-5679.
-
Daley CL, van Ingen J, Chalmers JD, Flume PA, Griffith DE, Hasegawa N, Morimoto K, Winthrop KL, Sheu CC, Avsar K, Andrisani D, Codecasa LR, Terschlüsen E, May D, Yuen DW, Wu P, Hassan M, Nevoret ML, Mange K. Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trial. Ann Am Thorac Soc. 2026 Apr 01; 23(4):536-547.
-
Yamagata HM, Padilla MS, Hamilton AG, Swingle KL, Thatte AS, Ricciardi AS, Agrawal A, Fitzgerald E, Poirier AJ, Geisler HC, Joseph RA, Chalom OZ, Du S, Li JJ, Kim D, Whitaker RC, Figueroa-Espada CG, Han EL, Murray AM, Alameh MG, Weissman D, Mitchell MJ. Liver-Detargeted Aromatic Bioreducible mRNA Lipid Nanoparticles Confer Lymph Node Tropism and Robust Antigen-Specific Immunity. J Am Chem Soc. 2026 04 08; 148(13):14137-14150.
-
Shi Q, Gong N, Wang J, Palanki R, Zheng Q, Alameh MG, Dwivedi G, Davis B, Melamed J, Luo Z, Xu J, Figueroa-Espada CG, Xue L, Zeng Y, Han X, Kim D, Chen Q, Yamagata H, Geisler HC, El-Mayta R, Yoon IC, Weissman D, Mitchell MJ. Prodrug-tethered lipid nanoparticles for synergistic messenger RNA cancer immunotherapy. Nat Nanotechnol. 2026 Mar; 21(3):430-442.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|